| Literature DB >> 34252679 |
Jyoti Bhardwaj1, Seongkyeol Hong2, Junbeom Jang1, Chang-Ho Han1, Jaegil Lee1, Jaesung Jang3.
Abstract
Air-transmissible pathogenic viruses, such as influenza viruses and coronaviruses, are some of the most fatal strains and spread rapidly by air, necessitating quick and stable measurements from sample air volumes to prevent further spread of diseases and to take appropriate steps rapidly. Measurements of airborne viruses generally require their collection into liquids or onto solid surfaces, with subsequent hydrosolization and then analysis using the growth method, nucleic-acid-based techniques, or immunoassays. Measurements can also be performed in real time without sampling, where species-specific determination is generally disabled. In this review, we introduce some recent advancements in the measurement of pathogenic airborne viruses. Air sampling and measurement technologies for viral aerosols are reviewed, with special focus on the effects of air sampling on damage to the sampled viruses and their measurements. Measurement of pathogenic airborne viruses is an interdisciplinary research area that requires understanding of both aerosol technology and biotechnology to effectively address the issues. Hence, this review is expected to provide some useful guidelines regarding appropriate air sampling and virus detection methods for particular applications.Entities:
Keywords: Air sampling; Air-transmissible pathogenic viruses; Virus measurement
Year: 2021 PMID: 34252679 PMCID: PMC8256664 DOI: 10.1016/j.jhazmat.2021.126574
Source DB: PubMed Journal: J Hazard Mater ISSN: 0304-3894 Impact factor: 10.588
Fig. 1Classification of viruses and examples. C: circular, L: linear, +: sense strand, -: antisense strand.
Fig. 2Structures of non-enveloped and enveloped viruses.
Minimum infective doses of respiratory disease viruses for humans with their sizes and survival times. S: spherical, I: icosahedral, I-S: icosahedral spherical, TCID50: fifty-percent tissue culture infective dose, E: enveloped, NE: non-enveloped.
| Viruses | Shape | Type | Size (nm) | Minimum infective dose (TCID50) | Survival time | References | |||
|---|---|---|---|---|---|---|---|---|---|
| Nasal drop | Aerosol | Non-porous | Porous | Skin | |||||
| Influenza A virus | S | E | 80–120 | 103 | 0.6–3.0 (H2N2) | 24–48 h | 8–12 h | 15 min | ( |
| Respiratory syncytial virus (RSV) | S | E | 30–40 | 30–40 | – | 6 h | 30–45 min | 20 min | ( |
| Parainfluenza virus | S | E | 150–250 | – | – | 10 h | 4 h | 1 h | ( |
| Adenovirus | I | NE | 90–100 | 35 | 0.5 | – | – | – | ( |
| Coronavirus | S | E | 80–160 | 13 (HCoV-229E) | – | 3–4 days | 30 min–7 days | 9 h | ( |
| Rhinovirus | S | NE | 30–50 | 0.032 | 0.68 | > 25 h | 1–24 h | 1–3 h | ( |
| Rubella virus | S | E | 60–70 | 0.2 | – | – | – | ( | |
| Coxsackievirus | I-S | NE | 30 | 6 | 28–34 | – | – | – | ( |
Fig. 3Transmission routes of COVID-19.
Studies on the size distribution of human or naturally generated viral aerosols. PTFE: polytetrafluoroethylene; OPC: optical particle counter; LPM: liters per min; qPCR: quantitative (real-time) polymerase chain reaction; NIOSH: National Institute for Occupational Safety and Health; qRT-PCR: quantitative reverse transcription-PCR; ddPCR: droplet-digital-PCR; TCID50: fifty-percent tissue culture infective dose; PC: polycarbonates; TEM: transmission electron microscope.
| References | Target | Sampling | Measurement | |||
|---|---|---|---|---|---|---|
| Virus | Generation or place | Sampler | Flow rate (LPM) | Method & Result | Comment | |
| ( | Influenza virus A (H3) & B | Tidal breathing by patients | PTFE filters | 28.3 | OPC | |
| ( | Influenza A virus | Coughing by patients | NIOSH sampler; | NIOSH sampler: 3.5; | qPCR | The viability of virus collected with the BioSampler was about 4 times higher than that with the NIOSH sampler (dry phase). |
| ( | Influenza virus A & B | Coughing by patients | Slit sampler with moisture condensation | 130 | qRT-PCR | About 50% of the infectious virus was lost during the concentration step. |
| ( | Influenza A & B; | Breathing and coughing by participants with respiratory symptoms | Andersen sampler | 28 | RT-PCR | |
| ( | Influenza A | Emergency department of a hospital | NIOSH sampler | 3.5 | qPCR | |
| ( | Influenza A | Isolation rooms of patients in a hospital (Hong Kong) | NIOSH sampler | 3.5 | # of RT-PCR positive samples | Influenza virus RNA recovery was associated with decreasing temperature and increasing relative humidity. |
| ( | Respiratory syncytial virus | Pediatric wards and intensive care units with infected babies (London) | Andersen sampler | 28.3 | Plaque assay | Detection of high virus concentrations may be due to suctioning of the endotracheal tube. |
| ( | SARS-CoV-2 | Hospital indoors (Wuhan) | Sioutas cascade impactor; | Sioutas impactor: 9; | ddPCR | Re-aerosolization of submicron viral particles from clothing was assumed. |
| ( | SARS-CoV-2 | Infection isolation rooms of patients in a hospital (Singapore) | NIOSH sampler | 3.5 | qPCR | The non-detection of virus in particles < 1 µm was assumed to be due to low extraction efficiency from filters compared with centrifuge tubes. |
| ( | SARS-CoV-2 | Rooms of patients in a hospital (North Carolina) | NIOSH sampler | 3.5 | # of qRT-PCR positive samples | No infectious virus was cultured from aerosol samples, which may be due to long-term (4 h) dry-phase sampling. |
| ( | SARS-CoV-2 | Rooms of patients in a hospital (Nebraska) | NIOSH sampler with a gelatin filter (<1 µm) | 3.5 | Mean qRT-PCR equivalent TCID50/m3 | Gelatin filter in the final stage of the sampler may help preserve intact virus (observed by TEM) during sampling. |
| ( | SARS-CoV-2 | Rooms of patients in a hospital (Quebec) | Gelatin filter; | Filters: 10; | qRT-PCR | Non-detection in SASS 3100 may be due to short sampling time (15 min), high sampling velocity, high-frequency vibration, and exposure to detergent during the extraction. |
Fig. 4Descending order of resistant pathogens (viruses, spores, fungi etc.) to UV light, which is one of the most common environmental stresses, and disinfectants.
Fig. 5General procedures of airborne virus measurements: sampling and identification.
Fig. 6Schematics of several air samplers used in studies on airborne viruses (Pan et al., 2019).
Air samplers used in studies on airborne viruses and their characteristics. PTFE: polytetrafluoroethylene; PC: polycarbonates.
| Filters | Impactors | Impingers | Cyclones | Electrostatic samplers | Condensation-based samplers | |
|---|---|---|---|---|---|---|
| Main principle | Interception Inertial impaction Diffusion Gravitational settling Electrostatic attraction | Inertial impaction on a solid surface | Inertial impingement on a liquid surface | Centrifugal & inertial impaction on a liquid (wet type) or solid (dry type) surface | Electrostatic attraction of pre-charged particles on a liquid (wet) or solid (dry) surface | Size increase via condensation and then impaction or impingement on a liquid (wet) or solid (dry) surface |
| Devices | PTEF, PC filters Gelatin filters | Slit sampler Andersen sampler | AGI-30 SKC BioSampler | Dry/wetted-wall cyclone sampler | Large volume sampler (LVS) | BioSpot-VIVAS |
| Advantages | Simplicity High collection efficiency | Size-selective sampling High flow rate | Relatively high biological recovery | High flow rate | High collection efficiency over a wide range of particle size | High collection efficiency High biological recovery |
| Disadvantages | Desiccation of samples Incompatibility with viability analysis | Low efficiency for submicron particles Low biological recovery | Low efficiency for submicron particles Fragile container | Low efficiency for submicron particles Relatively low biological recovery | Low sampling flow rate ROS generation | Low sampling flow rate Bulkiness and complexity |
| Main sources of damage and viability losses | Dehydration and desiccation of biological particles | High impaction of biological particles | High impaction of biological particles | High impaction of biological particles | High electric field intensity and corona charging | High temperature during sampling |
Studies on the measurement of artificially generated viral aerosols. FFU: focus forming unit; PFU: plaque forming unit; FI: fluorescence intensity; LPM: liters per minute; qPCR: quantitative (real-time) polymerase chain reaction; qRT-PCR: quantitative reverse transcription-PCR; TCID50: fifty-percent tissue culture infective dose; MMD: mass median diameter; PC: polycarbonates; PTFE: polytetrafluoroethylene; ESP: electrostatic precipitator; NW: nanowire; FET: field effect transistor; LOD: limit of detection; CMD: count median diameter; EID50: fifty-percent egg infective dose; GTC: growth tube collector; TCI: Tisch cascade impactor; NIOSH: National Institute for Occupational Safety and Health; ROS: reactive oxygen species.
| Sampler | References | Virus | Size | Flow rate (LPM) | Method | Result | Comments on viral damage |
|---|---|---|---|---|---|---|---|
| Impactor; | ( | Influenza virus (H1N1) | N/A | Impactor: 30; | Plaque assay; | Infectiousness ([qPCR/ FFU]initial /[qPCR /FFU]collected) | Liquid-based samplers preserved better virus infectivity than dry-media samplers. |
| Impactor | ( | MS2 bacteriophages; | N/A | Andersen sampler: 28.3; | Plaque assay; | Relative recovery ([Virus/FI]collected /[Virus/FI]initial) | |
| Impactor; | ( | MS2 bacteriophages | MMD: 4 µm | BioCapture 650: 200; | PFU; | Relative efficiency (PFUtest sampler/PFUBioSampler) | Dry-phase samplers decreased cultivability of MS2. |
| Impactor; | ( | Infectious bursal disease virus | 1–10 µm (0 min); | Andersen sampler: 28.3; | Egg endpoint dilution assay | Biological efficiency ([EID50/FI]collected /[EID50/FI]initial) | The tested virus seems to be more resistant to dehydration stress than shear stress. |
| Impactor | ( | Betaarterivirus suid 1; | N/A | Andersen sampler: 28.3; | RT-PCR | Log10 RNA copies/m3 | |
| Impinger; | ( | Influenza virus (H1N1) | N/A | BioSampler: 12.5; | Endpoint dilution assay; | Relative recovery (TCID50collected /TCID50initial) | Extracting process from glass fiber filters may deactivate the viruses. |
| Cyclone | ( | Influenza virus (H1N1) | CMD: 0.8 µm | Cyclone: 3.5; | Plaque assay; | Total viral particles per liter of sampled air | Virus infectivity in the cyclone was 34% of that in the BioSampler. |
| Cyclone | ( | Norovirus | N/A | NIOSH sampler: 3.5; | qPCR; | Airborne viral concentration (RNA copies/m3) | |
| Filter | ( | Phi X 174 bacteriophages; | MMD (μm), Phi X 174: 1.3; | 2 | Plaque assay; | Relative recovery (qPCRcollected /qPCRinitial) | |
| Condensation | ( | MS2 bacteriophages | N/A | 12.5 | Plaque assay | Factor multiplying collection efficiency (PFUon/PFUoff) | The collection efficiency was highest for a saturated air temperature of 65 °C. |
| Condensation | ( | MS2 bacteriophages | N/A | GTC: 7; | Plaque assay | Concentration in air (PFU/L) | Viable MS2 concentration decreased when initiator temperature increased to 60 °C. |
| Condensation | ( | Influenza virus (H1N1) | Mode diameter: 2.6 µm | VIVAS: 6.86; | Endpoint dilution assay | Collection efficiency (TCID50collected/ TCID50nebulized) | Collection efficiency decreased with the loss of virus viability during the collection process in the BioSampler. |
| Condensation | ( | MS2 bacteriophages | Mode diameter: 35 nm | GTC: 7; | Plaque assay; | Percent infectivity | Percent infectivity increased as the particle diameter increased. |
| Condensation | ( | MS2 bacteriophages | N/A | GTC: 7; | Plaque assay | Collection efficiency (PFUcollected/PFUnebulized) | The collection efficiency increased with relative humidity. |
| Condensation | ( | MS2 bacteriophages | N/A | 12.5 | Plaque assay | Viral aerosol collection enhancement factor (PFUon/PFUoff) | Viral aerosol collection enhancement factor decreased when mixing reservoir temperature increased to 50 °C. |
| ESP | ( | Influenza virus (H3N2) | N/A | 5 | Si-NW FET | Detection range (gene copies/µL) | LOD of < 104 viruses per liter of air |
| ESP | ( | MS2 &T3 | Mode: 36 nm | 1.2–12.5 | PFU; | Recovery rate ([PFU/qPCR]collected /[PFU/qPCR]initial) | The recovery rate decreased with sampling velocity in the BioSampler. |
| ESP | ( | Influenza virus | MMD: 1.074 µm | 6.8 | qPCR | Collection efficiency (qPCRESP/qPCRgelatin filter) | Additional extraction process was required to obtain high collection efficiency. |
| ESP | ( | Influenza virus (H1N1) | Mode: 36 nm | 1.2 | Electrochemical paper sensor | Detection limit (PFU/mL) | ROS in the ESP damaged hemagglutinin of the viruses. |
| ESP | ( | Human | Mode diameter, | 4–10 | qRT-PCR | Total enrichment capacities | Higher aerosol-to-hydrosol enrichment capacities were obtained for lower aerosol concentrations. |
Classification of detection methods that can be used for viral aerosols. TCID50: fifty-percent tissue culture infective dose, qPCR: quantitative polymerase chain reaction, ELISA: enzyme-linked immunosorbent assay, RIA: radio immunoassay, MALDI-TOF: matrix assisted laser desorption/ionization time-of-flight, ATP: adenosine triphosphate, PMA: propidium monoazide, QCM: quartz crystal microbalance, SPR: surface plasmon resonance, FET: field effects transistor, UVAPS: ultraviolet aerodynamic particle sizer, NADH: nicotinamide-adenine dinucleotide.
| Detection method | Type of detection | Specific to state of virus | Limitation | Comments | References |
|---|---|---|---|---|---|
| Culturing techniques | Plaque | Only plaque forming virus | Specific culture conditions necessary; cannot be used for non-infectious viruses | ( | |
| TCID50 | Both plaque forming and non-plaque forming infectious viruses | ||||
| Molecular | qPCR, droplet digital PCR, Isothermal PCR techniques | Plaque forming, non-plaque forming, and dead viruses (with intact DNA/RNA) | Quantification may be highly affected by contamination, nucleic acid extraction and improper sampling; time consuming | ( | |
| PMA-qPCR | Differentiate intact from compromised virions | ( | |||
| Immunoassay (Chemical tracer/Biochemical assay) | ELISA | Both plaque forming and non-plaque forming infectious virus. | Time consuming; knowledge about specific antibodies | No report on viral aerosols yet | ( |
| RIA | Specific chemical labeling | ||||
| Neuraminidase (NA) activity | Both plaque forming and non-plaque forming infectious viruses | NA activities are present for several viruses including influenza A, B, parainfluenza, and rubella viruses. Environmental stresses affect NA activity. | A commercialized kit is for influenza viruses only. | ( | |
| Affinity based sensors | QCM, SPR, FET, Electrochemical sensors | Both plaque forming and non-plaque forming infectious viruses. Dead viruses with intact protein or RNA/DNA | Surface protein based affinity sensors can fail to detect when the surface proteins of target viruses are degraded or damaged. | ( | |
| Microscopy | Electron microscopy | Both plaque forming and non-plaque infectious forming viruses. Dead viruses (with and without intact DNA), cell fragments or proteins | No reports on viral aerosol detection | ( | |
| Fluorescence based quantitative analysis | Flow cytometry | ( | |||
| Mass spectrometry | MALDI-TOF | plaque forming and non-plaque forming infectious viruses, dead and fragments | Compounds less than 600 Da in size cannot be detected | No reports on viral aerosol detection | ( |
| Optical | ATP bioluminescence | Cannot be used for any state of viruses | applicable to bacteria, fungi, and mycoplasma | This method is based on auto-fluorophores of bio-particles such as NADH etc., and metabolic activity markers such as ATP. | ( |
| UVAPS | Cannot be used for virus detection | Only applicable to viable bacteria & fungi |
Conventional and advanced methods for detection of viral aerosols. UTM: universal transport medium, NIOSH: National Institute for Occupational Safety and Health, G-II: Gesundheit-II, qPCR: quantitative polymerase chain reaction, ddPCR: droplet digital polymerase chain reaction, PFU: plaque forming units, NP swabs: nasopharyngeal swab, PBS: phosphate buffered saline, VTM: viral transport medium, HBSS: Hanks balanced salt solution, VIVAS: viable virus aerosol sampler, AAB: ammonium acetate buffer, DI: deionized water, TYB: tryptone yeast extract broth, BSA: bovine serum albumin, TCID50: 50% tissue culture infectious dose, EID50: 50% egg infectious dose, GTC: growth tube collector, PMA: propidium monoazide, UNMC: University of Nebraska Medical Center, AIIR: airborne infection isolation rooms, LAMP: loop-mediated isothermal amplification, SiNw: silicon nanowire, swCNT: sigle-walled carbon nanotube, EAD: electro aerodynamic, EBC: exhaled breath condensate.
| Detection method | Sampler | Target | Locations | Collection liquid | Detection limit | References |
|---|---|---|---|---|---|---|
| Growth, ELISA, and nucleic-acid-based methods | ||||||
| qPCR | NIOSH-2 | Influenza A virus | Virginia University Hospital | Lysis and binding solution | ( | |
| qPCR, Culture (Plaque assay) | NIOSH-2 | Influenza A virus | nasal swab and cough samples | UTM | qPCR= 83 copies/cough Plaque assay= 0.8 PFU/cough | ( |
| qPCR, Culture (Plaque assay) | G-II human source sampler | Influenza A virus | Exhaled breath | PBS+ 0.01% BSA | Plaque assay= 3.0 × 105 | ( |
| qPCR, Culture (Plaque assay) | G-II human source sampler | Influenza A virus | Breath, talk, cough, and sneeze | PBS+ 0.01% BSA | Plaque=fine aerosol (39%) & -NP swabs (89%) | ( |
| Culture assay (TCID50) | VIVAS | Influenza A virus (H1N1) | PBS+ 0.5% BSA | ( | ||
| Culture (Plaque assay), ELISA | VIVAS | Inflluenza A virus (H1N1 H3N2), Influenza B virus | Air samples at health care center | PBS+ 0.5% BSA | ( | |
| Culture (Plaque assay) | GTC | MS2 | 1.5 mL of DI water or TYB | DI= 442 ± 305 PFU/ L | ( | |
| Culture (Plaque assay), qPCR | NIOSH-2 | Norovirus | Healthcare facilities of Quebec City | PBS | ( | |
| RT-PCR | Personal Cascade Impactor Sampler | Influenza A virus (H3N2) | apartment | PBS with 0.5% w/v BSA | ( | |
| PMA-qPCR | SKC BioSampler and NIOSH-251 | Murine norovirus (surrogate virus) | Laboratory | PBS and HBSS | SKC BioSampler- 8.78 × 104 (HBSS) and 4.75 × 104 RNA copies/m3 (PBS) | ( |
| ddPCR | Cascade impactor and Filters | SARS-CoV-2 | Hospital indoors (Wuhan) | Filters dissolved in DI water | Peak RNA concentration in the protective-apparel removal room (copies/m3), | ( |
| Real time RT-PCR, Culture assay (TCID50) | Sartorius Airport MD8 air sampler with gelatin filter 80 mm) | SARS-CoV-2 | UNMC (Patient’s room) | PBS | 0–1.75 copies/µL or 2.86 copies/L of air | ( |
| Real time RT-PCR | Sartorius MD8 air scan with gelatin filter (80 mm, 3 µm pore size) | SARS-CoV-2 | Air sample-AIIRs, | VTM | AIIR-9.2 × 102 copies/mL, | ( |
| Real time RT-PCR | ESP | Human coronavirus 229E; | Laboratory (artificially generated) | DI-water, PBS | Enrichment method -Con-A coated magnetic beads | ( |
| Paper based RT-LAMP | VIVAS | Influenza A H1N1 | Laboratory (artificially generated) | PBS+ 0.5% BSA | 1TCID50/140 µL | ( |
| Biosensors | ||||||
| FET-immunosensor (SiNw) | Electrostatic sampler | Influenza A virus (H3N2) | Laboratory (stock virus) | DI water | 104 virus µL-1 | ( |
| FET- immunosensor (SiNw) | BioStage impactor (SKC) | Influenza A virus (H3N2) | Laboratory-EBC | DI water | 29 viruses µL-1 | ( |
| FET-immunosensor (swCNT) | EAD | Influenza A virus (H1N1) and MS2 | Laboratory-(stock virus) | PBS | – | ( |
| QCM immunosensor | Influenza A virus (H3N2) | Laboratory-(stock virus) | 4 viruses mL-1 | ( | ||
| QCM sensor | Impactor | Vaccinia virus | Laboratory- (stock virus) | 40 particles ∕mL at a flow rate of 2.0 l/min | ( | |
| Near infrared (NIR) based LFA (Sandwich immunoassay) | Filter-based air sampler | MS2, Influenza A (H1N1) | Laboratory-(stock virus) | PBS | 103 EID50/mL (for H1N1) | ( |
| Electrochemical immunosensor (Paper-sandwich assay) | Electrostatic sampler (EPC) | Influenza A virus (H1N1) | Laboratory-(stock virus) | PBS | 2.13 PFU/mL for NP Ab | ( |
Fig. 7(A) Schematics of qPCR and droplet digital PCR (image modified from Tan et al. (2021)), (B) workflow of the isothermal amplification process (image taken from Khan et al. (2020) with permission, © 2020 American Chemical Society), and (C) paper-based isothermal amplification technique (RT-LAMP) integrated with VIVAS for collection and detection of airborne influenza A H1N1 viruses (image taken from Jiang et al. (2021)).
Fig. 8Integrated sensor system with air samplers for detection of airborne viruses; (A) real-time quartz crystal microbalance sensor for detection of vaccinia viruses (image taken from Lee et al. (2008) with permission © 2008 American Institute of Physics Publishing LLC), (B) automated microfluidic nanowire-based FET immunosensor for detection of influenza A H3N2 viruses (image taken from Shen et al. (2011a)), (C) vertical flow assay (VFA)-based electrochemical paper immunosensor integrated with an electrostatic particle concentrator (EPC) for detection of influenza A H1N1 viruses (image taken from Bhardwaj et al. (2020)), and (D) lateral flow assay (LFA)-based optical immunosensor for detection of airborne influenza A H1N1 viruses and MS2 bacteriophages (image taken from (Lee et al. (2020)).